melagatran has been researched along with gabexate in 1 studies
| Studies (melagatran) | Trials (melagatran) | Recent Studies (post-2010) (melagatran) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
|---|---|---|---|---|---|
| 185 | 32 | 19 | 743 | 53 | 106 |
| Protein | Taxonomy | melagatran (IC50) | gabexate (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
| Coagulation factor X | Homo sapiens (human) | 4.61 | |
| Plasminogen | Homo sapiens (human) | 0.431 | |
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
| Serine protease hepsin | Homo sapiens (human) | 0.383 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilgram, O; Steinmetzer, T; Wenzel, BM; Wiedemeyer, SJA | 1 |
1 other study(ies) available for melagatran and gabexate
| Article | Year |
|---|---|
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
Topics: Animals; Antifibrinolytic Agents; Catalytic Domain; Crystallography, X-Ray; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Ligands; Molecular Structure; Plasminogen; Protein Binding; Protein Domains | 2020 |